Select a metric from the list below to chart it
Metric | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | LTM |
|---|---|---|---|---|---|---|
Total Revenues | 6,196.0 | 5,812.8 | 4,851.0 | 6,585.0 | 8,108.0 | 7,861.0 |
Total Revenues % Chg. | — | -6.2% | -16.5% | 35.7% | 23.1% | 5.1% |
Cost of Goods Sold, Total | 6,646.1 | 6,345.0 | 5,563.0 | 5,572.0 | 5,869.0 | 5,582.0 |
Gross Profit | -450.1 | -532.2 | -712.0 | 1,013.0 | 2,239.0 | 2,279.0 |
Selling General & Admin Expenses, Total | 452.7 | 445.6 | 445.0 | 595.0 | 496.0 | 502.0 |
R&D Expenses | 926.2 | 583.0 | 476.0 | 478.0 | 482.0 | 449.0 |
Other Operating Expenses, Total | 1,379.0 | 1,028.6 | 921.0 | 1,073.0 | 978.0 | 951.0 |
Operating Income | -1,829.0 | -1,560.8 | -1,633.0 | -60.0 | 1,261.0 | 1,328.0 |
Interest Expense, Total | -137.5 | -202.8 | -133.0 | -99.0 | -92.0 | -45.0 |
Interest And Investment Income | 10.3 | 11.4 | 3.0 | 6.0 | 51.0 | 52.0 |
Net Interest Expenses | -127.2 | -191.4 | -130.0 | -93.0 | -41.0 | 7.0 |
Income (Loss) On Equity Invest. | 6.9 | 7.9 | — | — | — | — |
Other Non Operating Income (Expenses) | -27.3 | -27.4 | -51.0 | -62.0 | -100.0 | -149.0 |
EBT, Excl. Unusual Items | -1,976.6 | -1,771.8 | -1,814.0 | -215.0 | 1,120.0 | 1,186.0 |
Restructuring Charges | -112.0 | — | — | — | -94.0 | -118.0 |
Gain (Loss) On Sale Of Investments | — | — | 38.0 | — | — | — |
Gain (Loss) On Sale Of Assets | 61.3 | 688.6 | 140.0 | 39.0 | 506.0 | 506.0 |
Asset Writedown | -582.2 | -64.0 | -23.0 | — | — | — |
Legal Settlements | — | — | 294.0 | — | — | — |
EBT, Incl. Unusual Items | -2,609.6 | -1,147.1 | -1,365.0 | -176.0 | 1,532.0 | 1,574.0 |
Income Tax Expense | 16.4 | 224.1 | -12.0 | 78.0 | 86.0 | 78.0 |
Earnings From Continuing Operations | -2,626.0 | -1,371.2 | -1,353.0 | -254.0 | 1,446.0 | 1,496.0 |
Earnings Of Discontinued Operations | -148.0 | — | — | — | — | — |
Minority Interest | 72.4 | — | 3.0 | 4.0 | 2.0 | 4.0 |
Net Income | -2,701.6 | -1,371.2 | -1,350.0 | -250.0 | 1,448.0 | 1,500.0 |
Preferred Dividend and Other Adjustments | — | — | — | — | — | 1.0 |
Net Income to Common Incl Extra Items | -2,701.6 | -1,371.2 | -1,350.0 | -250.0 | 1,448.0 | 1,499.0 |
Net Income to Common Excl. Extra Items | -2,553.6 | -1,371.2 | -1,350.0 | -250.0 | 1,448.0 | 1,499.0 |
Total Shares Outstanding | 576.9 | 504.0 | 500.0 | 531.8 | 547.8 | 552.7 |
Weighted Avg. Shares Outstanding | 576.9 | 504.0 | 500.0 | 506.0 | 539.0 | 547.5 |
Weighted Avg. Shares Outstanding Dil | 576.9 | 504.0 | 500.0 | 506.0 | 552.0 | 555.0 |
EPS | -4.7 | -2.7 | -2.7 | -0.5 | 2.7 | 2.7 |
EPS Diluted | -4.7 | -2.7 | -2.7 | -0.5 | 2.6 | 2.7 |
EBITDA | 1,118.9 | 1,117.4 | 889.0 | 1,543.0 | 2,874.0 | 2,805.0 |